Lifeboat Foundation

She’s now leading her own $39m Longevity Fund that supports entrepreneurs developing therapies for age-related diseases.

Born in New Zealand, Deming was home-schooled by her parents but as a child taught herself calculus, probability and statistics as well as French literature and history.

After her grandmother Bertie developed neuro-muscular problems in her 70s and 80s, she decided to dedicate her life to combating the ageing process.

The rise of cryptocurrency is changing the philanthropic world by causing the redistribution of wealth from old money to visionary innovators and early tech adopters. The new crypto rich invest their donations by supporting scientific research in groundbreaking fields that may one day enable humanity to cure aging, reverse death and completely change the relationship between work and income.

Also Read: How Does a Country Do an ICO? They Call It QE

Examining the record of donations made by the crypto rich reveals a pattern of support for goals that others may feel belong in the pages of science fiction novels. Having benefited greatly from recognizing the potential of peer to peer electronic cash earlier than the masses, it is no surprise that they have great optimism in the power of technology to radically change our lives for the better.

Scientists have produced and tested, in mice, a vaccine that protects against a worrisome superbug: a hypervirulent form of the bacteria Klebsiella pneumoniae. And they’ve done so by genetically manipulating a harmless form of E. coli, report researchers at Washington University School of Medicine in St. Louis and VaxNewMo, a St. Louis-based startup.

Klebsiella pneumoniae causes a variety of infections including rare but life-threatening liver, respiratory tract, bloodstream and other infections. Little is known about how exactly people become infected, and the bacteria are unusually adept at acquiring resistance to antibiotics. The prototype vaccine, details of which are published online Aug. 27 in Proceedings of the National Academy of Sciences, may offer a way to protect people against a lethal infection that is hard to prevent and treat.

“For a long time, Klebsiella was primarily an issue in the hospital setting, so even though drug resistance was a real problem in treating these infections, the impact on the public was limited,” said co-author David A. Rosen, MD, Ph.D., an assistant professor of pediatrics and of molecular microbiology at Washington University. “But now we’re seeing Klebsiella strains that are virulent enough to cause death or severe disease in healthy people in the community. And in the past five years, the really resistant bugs and the really virulent bugs have begun to merge so we’re beginning to see drug-resistant, hypervirulent strains. And that’s very scary.”

FINDLAY, Ohio — Pharmacy students at the University of Findlay believe they’ve developed a new drug that could target the most aggressive form of cancer occurring in the brain.

The oral compound, RK15, targets glioblastomas, an aggressive brain cancer. The disease has a 10 percent, five-year survival rate.

If it’s successful, the medication would remove the need for risky medical procedures which require physical access to brain tissue, according to the University of Findlay.

Singularity University, Singularity Hub, Singularity Summit, SU Labs, Singularity Labs, Exponential Medicine, Exponential Finance and all associated logos and design elements are trademarks and/or service marks of Singularity Education Group.

© 2019 Singularity Education Group. All Rights Reserved.

Singularity University is not a degree granting institution.

A team of Australian researchers has designed a reliable strategy for testing physical abilities of humanoid robots—robots that resemble the human body shape in their build and design. Using a blend of machine learning methods and algorithms, the research team succeeded in enabling test robots to effectively react to unknown changes in the simulated environment, improving their odds of functioning in the real world.

The findings, which were published in a joint publication of the IEEE and the Chinese Association of Automation Journal of Automatica Sinica in July, have promising implications in the broad use of humanoid robots in fields such as healthcare, education, disaster response and entertainment.

“Humanoid robots have the ability to move around in many ways and thereby imitate human motions to complete complex tasks. In order to be able to do that, their stability is essential, especially under dynamic and unpredictable conditions,” said corresponding author Dacheng Tao, Professor and ARC Laureate Fellow in the School of Computer Science and the Faculty of Engineering at the University of Sydney.

Wearing a flower brooch that blooms before your eyes sounds like magic. KAIST researchers have made it real with robotic muscles.

Researchers have developed an ultrathin, artificial muscle for soft robotics. The advancement, recently reported in the journal Science Robotics, was demonstrated with a robotic blooming flower brooch, dancing robotic butterflies and fluttering tree leaves on a kinetic art piece.

The robotic equivalent of a muscle that can move is called an actuator. The actuator expands, contracts or rotates like muscle fibers using a stimulus such as electricity. Engineers around the world are striving to develop more dynamic actuators that respond quickly, can bend without breaking, and are very durable. Soft, robotic muscles could have a wide variety of applications, from wearable electronics to advanced prosthetics.

A deadly outbreak of “superbug” salmonella sprung up in the US late last year. While this is certainly not the first time drug-resistant bugs have been found in the US, the outbreak marks yet another milestone on the road to a future without antibiotics.

Over 250 people across 32 states fell sick with a strain of Salmonella that’s resistant to multiple antibiotics between June 2018 and March 2019, according to a recent Morbidity and Mortality Weekly Report from the US Centers for Disease Control and Prevention (CDC). At least two people died from the infection, and a further 60 cases were so severe that they required hospitalization.

The outbreak of antibiotic-resistant Salmonella infections was linked back to beef bought in the US and a “Mexican-style soft cheese” obtained in Mexico. They found that the strain didn’t respond to ciprofloxacin and had “decreased susceptibility” to azithromycin, two of the main antibiotic drugs used to treat Salmonella infections. The unusual strain – known as Salmonella enterica serotype Newport – emerged no later than 2016 and is still continuing to spread among cattle.